Your browser doesn't support javascript.
loading
Five-year follow-up after live donor nephrectomy - cross-sectional and longitudinal analysis of a prospective cohort within the era of extended donor eligibility criteria.
Janki, Shiromani; Dols, Leonienke F C; Timman, Reinier; Mulder, Evalyn E A P; Dooper, Ine M M; van de Wetering, Jacqueline; IJzermans, Jan N M.
  • Janki S; Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Dols LF; Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Timman R; Department of Psychiatry, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Mulder EE; Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Dooper IM; Department of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van de Wetering J; Department of Nephrology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • IJzermans JN; Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Transpl Int ; 30(3): 266-276, 2017 Mar.
Article en En | MEDLINE | ID: mdl-27717017
ABSTRACT
To establish the outcome of live kidney donors 5 years after donation, we investigated the risk for progressive renal function decline and quality of life (QoL). Data on estimated glomerular filtration rate (eGFR), creatinine, hypertension, QoL and survival were assessed in a prospective cohort of 190 donors, who donated between 2008 and 2010. Data were available for >90%. The mean age predonation was 52.8 ± 11.5 years, 30 donors having pre-existent hypertension. The mean follow-up was 5.1 ± 0.9 years. Eight donors had died due to non-donation-related causes. After 5 years, the mean eGFR was 60.2 (95% CI 58.7-62.7) ml/min/1.73 m2 , with a median serum creatinine of 105.1 (95% CI 102.5-107.8) µmol/l. eGFR decreased to 33.6% and was longitudinally lower among men than women and declining with age (P < 0.001), without any association on QoL. Donors with pre-existent and new-onset hypertension demonstrated no progressive decline of renal function overtime compared to nonhypertensives. No donors were found with proteinuria, microalbuminuria or at risk for end-stage renal disease. After an initial decline postdonation, renal function remained unchanged overtime. Men and ageing seem to affect renal function overtime, while decreased renal function did not affect QoL. These data support further stimulation of living kidney donation programmes as seen from the perspective of donor safety.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Donadores Vivos / Nefrectomía Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Donadores Vivos / Nefrectomía Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article